Senior Director, Program Management

Aditum Bio is a new model of biotech venture capital uniquely positioned to rapidly translate scientific discoveries into innovative new medicines. Aditum brings together unmatched scientific and domain expertise, combined with operational capabilities. Our agile operating model enables rapid company formation, planning, and execution for a new model of drug development. We target clinic-ready therapies to help underserved patient populations, rapidly forming companies and staffing them with medical and scientific experts. Launched in 2019 by former Novartis CEO Joe Jimenez and former President of the Novartis Institutes for Biomedical Research, Dr. Mark Fishman, Aditum currently manages a broad portfolio of clinical stage companies with multiple drug candidates in or entering Phase 2 clinical trials.

Position Summary:

We are seeking a program management leader who will be responsible for leading overall development project management within a newly-launched Aditum Bio portfolio company. As an employee of the Aditum Bio Services team, you'd be a part of a talented group of experts working to incubate an early stage biotech company, with the potential to pivot to different portfolio programs over time. The program manager will work cross-functionally across internal and external stakeholders to strategically and efficiently drive progress toward clinical milestones of a given Aditum Bio portfolio company. 

Specific Responsibilities:

• Program Planning and Management: Work with the Aditum Bio stakeholders to manage the development plan and coordinate all the moving pieces to deliver on execution. Work across functions to develop timelines and budgets for asset progression, closely track progress, proactively identify risks and potential mitigations, and report results to Aditum Bio management team
• Partner Collaborations and Vendor Management: Manage the contracting and oversight of any external partners, including contract manufacturers, API and formulation advisors, preclinical CROs and consultants, while ensuring that the interests of Aditum Bio are protected. Work collaboratively with CROs to execute and track clinical development programs.
• Asset/Tech Transfer: Working closely with the Aditum Bio BD&L team and the asset seller to efficiently transfer assets post deal close to Aditum Bio and its vendors/partners. Closely managing execution for successful asset transfer to Aditum Bio and into the portfolio company in which the asset will be housed.
• Coordinate activities of asset sales: At asset value inflection, work with the Aditum Bio BD&L team to coordinate and execute on asset exit (e.g., transfer of asset to new buyer, IPO activities and management, syndication for next phase of development, etc.)

Qualifications:

• BA/BS, with a background in science/biotechnology/medicine. Experience in drug development project management is a must.
• Experience working on small teams, within fast-paced, early stage biotech companies.
• Experience spanning tech transfer, pre-clinical and clinical development. Experience managing CMC is beneficial. 
• Strong track record in effectively working with senior management
• Proven ability to work collaboratively internally and externally, with the ability to manage multiple stakeholders
• Results oriented and self-assured. Ability to push timetables while keeping the team motivated